Seattle Genetics Inc. has a market cap of $1.62 billion; its shares were traded at around $14.28 with and P/S ratio of 15.2. Seattle Genetics Inc. had an annual average earning growth of 2.2% over the past 10 years.
This is the insider trade history vs. stock price of SGEN. For the complete insider trading history of SGEN, click here.
Directors and Officers Recent Trades:
- Buy: Director, 10% Owner Capital (gp), Llc 14159 bought 48,197 shares of SGEN stock on 02/02/2011 at the average price of 15.5. Capital (gp), Llc 14159 owns at least 303,449 shares after this. The price of the stock has decreased by 7.87% since.
- Buy: Director, 10% Owner Brothers Life Sciences C Baker bought 1,751,803 shares of SGEN stock on 02/02/2011 at the average price of 15.5. Brothers Life Sciences C Baker owns at least 13,470,692 shares after this. The price of the stock has decreased by 7.87% since.
- Sell: EVP, Process Sciences Morris Rosenberg sold 25,000 shares of SGEN stock on 12/15/2010 at the average price of 16.22. The price of the stock has decreased by 11.96% since.
- Sell: EVP, Process Sciences Morris Rosenberg sold 25,000 shares of SGEN stock on 12/02/2010 at the average price of 15.81. The price of the stock has decreased by 9.68% since.
- Sell: EVP, Process Sciences Morris Rosenberg sold 25,000 shares of SGEN stock on 11/04/2010 at the average price of 14.7. The price of the stock has decreased by 2.86% since.
For the complete insider trading history of SGEN, click here.






RSS